# Aura Biosciences, Inc. (AURA) MD&A by fiscal year

Verbatim Item 7 Management's Discussion and Analysis sections from Aura Biosciences, Inc.'s 10-K filings, one page per fiscal year. Extracted from SEC filings with the same bounded parser for every year. Filer text, not grepcent analysis or investment advice.

- [FY 2025 MD&A](/company/AURA/mda/fy2025/): filed 2026-03-30; accession 0001193125-26-130401 (https://www.sec.gov/Archives/edgar/data/1501796/000119312526130401/aura-20251231.htm); latest 10-K
- [FY 2024 MD&A](/company/AURA/mda/fy2024/): filed 2025-03-24; accession 0000950170-25-043943 (https://www.sec.gov/Archives/edgar/data/1501796/000095017025043943/aura-20241231.htm)
- [FY 2023 MD&A](/company/AURA/mda/fy2023/): filed 2024-03-27; accession 0000950170-24-036814 (https://www.sec.gov/Archives/edgar/data/1501796/000095017024036814/aura-20231231.htm)
- [FY 2022 MD&A](/company/AURA/mda/fy2022/): filed 2023-03-15; accession 0000950170-23-008166 (https://www.sec.gov/Archives/edgar/data/1501796/000095017023008166/aura-20221231.htm)
- [FY 2021 MD&A](/company/AURA/mda/fy2021/): filed 2022-03-23; accession 0000950170-22-004425 (https://www.sec.gov/Archives/edgar/data/1501796/000095017022004425/aura-20211231.htm)

Back to /company/AURA/